Latest Updates on the Ozempic Gallstone Lawsuit Revealed by Lawsuit Legal News

Lawsuit Legal News

New Orleans, LA – Ozempic, a medicine often used to treat diabetes, has been linked to causing gallstones in patients. In recent months, patients have come forward saying they developed gallstones after taking Ozempic. The company that makes the drug, Novo Nordisk, is being accused of failing to provide an accurate warning label for its product. As a result, Ozempic users are now pursuing product liability claims against the makers of Ozempic to recover compensation for financial damages including medical bills, lost wages, and even pain and suffering. While gallstones may not seem like a big deal to some, if they aren’t treated, they can cause serious health problems.

People with Type II Diabetes often rely on medication to help manage their condition, in addition to maintaining their diet and establishing an exercise routine. Ozempic, an injectable medication that is also sold under the names Wegovy and Rybelsus, has been marketed to Type II diabetics as a way to help reduce their blood sugar levels.

Because one of its side effects helps people lose weight, Ozempic—the brand name for the chemical compound Semaglutide—has also been used by some to achieve weight loss. Unfortunately, new reports reveal some Ozempic users are experiencing severe gallbladder issues after receiving the drug. Many of these users have filed Ozempic lawsuits to recover their losses.

You may be eligible to bring an Ozempic lawsuit if you meet certain conditions. Specifically, you must have:

  • Used Ozempic prior to April 2022
  • Suffered gallbladder injuries, such as gallstones
  • Sustained financial damages as a result of your gallbladder injuries

Lawsuit Legal News is working hard to shed light on this lawsuit. Their team of skilled journalists and lawyers has been following the case closely to ensure they provide the most accurate information. A big part of the lawsuit is the growing number of patients claiming they weren’t told about the risk of gallstones.

Due to the Ozempic gallstone lawsuit, groups like the FDA are taking a closer look at how they approve drugs. If they make big changes, it could cause a significant shift in how the medicine industry handles drug safety and communication.

Lawsuit Legal News continues to be a dependable source for the latest legal news across the nation. They are committed to providing accurate, detailed, and current reports on important lawsuits.

Stay tuned for more updates on the Ozempic Gallstone lawsuit and other big legal news across the country by visiting

Bjorklund v. Novo Nordisk, et al.
U.S. District Court, Western District of Louisianna, Lake Charles Division
Case No. 2:23-cv-01020 provides authoritative, comprehensive, and balanced legal reporting on a national level. We are committed to delivering timely and accurate news, priding ourselves on our meticulous coverage of crucial lawsuits and legal developments that impact millions. Our team is comprised of experienced journalists and lawyers who delve into complex legal proceedings, distilling them into clear, actionable information for our readers. At, we ensure that our reporting is always factually accurate and balanced, keeping our audience fully informed about the legal landscape. We also offer free consultations with seasoned attorneys for those who believe they have a claim.

Lawsuit Legal News
Press Contact : Kat Taylor

Distributed by Law Firm Newswire
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.